These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10891089)

  • 1. Insensitivity of perturbed carboxyl pK(a) values in the ovomucoid third domain to charge replacement at a neighboring residue.
    Forsyth WR; Robertson AD
    Biochemistry; 2000 Jul; 39(27):8067-72. PubMed ID: 10891089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two conformational states of Turkey ovomucoid third domain at low pH: three-dimensional structures, internal dynamics, and interconversion kinetics and thermodynamics.
    Song J; Laskowski M; Qasim MA; Markley JL
    Biochemistry; 2003 Jun; 42(21):6380-91. PubMed ID: 12767219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. pH, ionic strength, and temperature dependences of ionization equilibria for the carboxyl groups in turkey ovomucoid third domain.
    Schaller W; Robertson AD
    Biochemistry; 1995 Apr; 34(14):4714-23. PubMed ID: 7718577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrostatic interactions in ubiquitin: stabilization of carboxylates by lysine amino groups.
    Sundd M; Iverson N; Ibarra-Molero B; Sanchez-Ruiz JM; Robertson AD
    Biochemistry; 2002 Jun; 41(24):7586-96. PubMed ID: 12056889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMR determination of pKa values for Asp, Glu, His, and Lys mutants at each variable contiguous enzyme-inhibitor contact position of the turkey ovomucoid third domain.
    Song J; Laskowski M; Qasim MA; Markley JL
    Biochemistry; 2003 Mar; 42(10):2847-56. PubMed ID: 12627950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constant-pH molecular dynamics study of protonation-structure relationship in a heptapeptide derived from ovomucoid third domain.
    Długosz M; Antosiewicz JM; Robertson AD
    Phys Rev E Stat Nonlin Soft Matter Phys; 2004 Feb; 69(2 Pt 1):021915. PubMed ID: 14995499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theoretical and experimental analysis of ionization equilibria in ovomucoid third domain.
    Forsyth WR; Gilson MK; Antosiewicz J; Jaren OR; Robertson AD
    Biochemistry; 1998 Jun; 37(24):8643-52. PubMed ID: 9628726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissecting the electrostatic interactions and pH-dependent activity of a family 11 glycosidase.
    Joshi MD; Sidhu G; Nielsen JE; Brayer GD; Withers SG; McIntosh LP
    Biochemistry; 2001 Aug; 40(34):10115-39. PubMed ID: 11513590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The determinants of carboxyl pKa values in turkey ovomucoid third domain.
    Li H; Robertson AD; Jensen JH
    Proteins; 2004 May; 55(3):689-704. PubMed ID: 15103631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solution structure of reactive-site hydrolyzed turkey ovomucoid third domain by nuclear magnetic resonance and distance geometry methods.
    Walkenhorst WF; Krezel AM; Rhyu GI; Markley JL
    J Mol Biol; 1994 Sep; 242(3):215-30. PubMed ID: 8089843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of peptide bonds to inhibitor-protease binding: crystal structures of the turkey ovomucoid third domain backbone variants OMTKY3-Pro18I and OMTKY3-psi[COO]-Leu18I in complex with Streptomyces griseus proteinase B (SGPB) and the structure of the free inhibitor, OMTKY-3-psi[CH2NH2+]-Asp19I.
    Bateman KS; Huang K; Anderson S; Lu W; Qasim MA; Laskowski M; James MN
    J Mol Biol; 2001 Jan; 305(4):839-49. PubMed ID: 11162096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NMR chemical shift mapping of the binding site of a protein proteinase inhibitor: changes in the (1)H, (13)C and (15)N NMR chemical shifts of turkey ovomucoid third domain upon binding to bovine chymotrypsin A(alpha).
    Song J; Markley JL
    J Mol Recognit; 2001; 14(3):166-71. PubMed ID: 11391787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assignment of the 13C-NMR spectra of virgin and reactive-site modified turkey ovomucoid third domain.
    Robertson AD; Rhyu GI; Westler WM; Markley JL
    Biopolymers; 1990 Feb; 29(2):461-7. PubMed ID: 2331509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissecting structural and electrostatic interactions of charged groups in alpha-sarcin. An NMR study of some mutants involving the catalytic residues.
    García-Mayoral MF; Pérez-Cañadillas JM; Santoro J; Ibarra-Molero B; Sanchez-Ruiz JM; Lacadena J; Martínez del Pozo A; Gavilanes JG; Rico M; Bruix M
    Biochemistry; 2003 Nov; 42(45):13122-33. PubMed ID: 14609322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of pK(a) values of carboxyl groups in the N-terminal domain of rat CD2: anomalous pK(a) of a glutamate on the ligand-binding surface.
    Chen HA; Pfuhl M; McAlister MS; Driscoll PC
    Biochemistry; 2000 Jun; 39(23):6814-24. PubMed ID: 10841761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of buried charged groups on cysteine thiol ionization and reactivity in Escherichia coli thioredoxin: structural and functional characterization of mutants of Asp 26 and Lys 57.
    Dyson HJ; Jeng MF; Tennant LL; Slaby I; Lindell M; Cui DS; Kuprin S; Holmgren A
    Biochemistry; 1997 Mar; 36(9):2622-36. PubMed ID: 9054569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Water molecules participate in proteinase-inhibitor interactions: crystal structures of Leu18, Ala18, and Gly18 variants of turkey ovomucoid inhibitor third domain complexed with Streptomyces griseus proteinase B.
    Huang K; Lu W; Anderson S; Laskowski M; James MN
    Protein Sci; 1995 Oct; 4(10):1985-97. PubMed ID: 8535235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of mutations of the active site arginine residues in 4-oxalocrotonate tautomerase on the pKa values of active site residues and on the pH dependence of catalysis.
    Czerwinski RM; Harris TK; Johnson WH; Legler PM; Stivers JT; Mildvan AS; Whitman CP
    Biochemistry; 1999 Sep; 38(38):12358-66. PubMed ID: 10493803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stabilization of a fibronectin type III domain by the removal of unfavorable electrostatic interactions on the protein surface.
    Koide A; Jordan MR; Horner SR; Batori V; Koide S
    Biochemistry; 2001 Aug; 40(34):10326-33. PubMed ID: 11513611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-dimensional NMR studies of Kazal proteinase inhibitors. 2. Sequence-specific assignments and secondary structure of reactive site modified turkey ovomucoid third domain.
    Rhyu GI; Markley JL
    Biochemistry; 1988 Apr; 27(7):2529-39. PubMed ID: 3382637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.